CSIMarket
 


Organicell Regenerative Medicine Inc   (BPSR)
Other Ticker:  
 
 

BPSR's Operating Income Growth by Quarter and Year

Organicell Regenerative Medicine Inc 's Operating Income results by quarter and year




BPSR Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter October - -5.15 -0.71 4.25
III Quarter July -1.39 -5.25 -0.34 -0.30
II Quarter April -2.23 -1.36 -0.44 -2.36
I Quarter January -8.17 -0.69 -0.29 -0.41
FY   -11.79 -12.45 -1.78 1.18



BPSR Operating Income third quarter 2021 Y/Y Growth Comment
Organicell Regenerative Medicine Inc in the third quarter recorded Operating Loss of $ -1.39 millions.

According to the results reported in the third quarter, Organicell Regenerative Medicine Inc achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Organicell Regenerative Medicine Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


BPSR Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY   - - - -

Financial Statements
Organicell Regenerative Medicine Inc 's third quarter 2021 Operating Income $ -1.39 millions BPSR's Income Statement
Organicell Regenerative Medicine Inc 's third quarter 2020 Operating Income $ -5.25 millions Quarterly BPSR's Income Statement
New: More BPSR's historic Operating Income Growth >>


BPSR Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Organicell Regenerative Medicine Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BPSR's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Organicell Regenerative Medicine Inc in the III. Quarter 2021 admitted Operating Loss of $ -1.39 millions, it should be point out, that current results are slight up side compare to the -2.23 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Organicell Regenerative Medicine Inc achieved highest sequential Operating Income growth. While Organicell Regenerative Medicine Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BPSR's III. Quarter Q/Q Operating Income Comment
Although Organicell Regenerative Medicine Inc in the III. Quarter 2021 showed Operating Loss of $ -1.39 millions, it should be mentioned, that current results are slight up side relative to the -2.23 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Organicell Regenerative Medicine Inc achieved highest sequential Operating Income growth. While Organicell Regenerative Medicine Inc 's Operating Income growth quarter on quarter, overall rank is .


Organicell Regenerative Medicine Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jul 31 2021)
12 Months Ending
(Apr 30 2021)
12 Months Ending
(Jan 31 2021)
12 Months Ending
(Oct 31 2020)
12 Months Ending
(Jul 31 2020)
Cumulative Operating Income 12 Months Ending $ -16.94 $ -20.79 $ -19.91 $ -12.44 $ -8.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Organicell Regenerative Medicine Inc ' has realized cumulative trailing twelve months Operating Loss of $ -17 millions in the Jul 31 2021 period.

Organicell Regenerative Medicine Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Organicell Regenerative Medicine Inc ' has realized cumulative trailing twelve months Operating Loss of $ -17 millions in the Jul 31 2021 period.

Organicell Regenerative Medicine Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
BPSR's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for BPSR's Competitors
Operating Income Growth for Organicell Regenerative Medicine Inc 's Suppliers
Operating Income Growth for BPSR's Customers

You may also want to know
BPSR's Annual Growth Rates BPSR's Profitability Ratios BPSR's Asset Turnover Ratio BPSR's Dividend Growth
BPSR's Roe BPSR's Valuation Ratios BPSR's Financial Strength Ratios BPSR's Dividend Payout Ratio
BPSR's Roa BPSR's Inventory Turnover Ratio BPSR's Growth Rates BPSR's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Jul 31 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jul 31 2021
Lakeland Industries Inc -59.66%$ -59.657 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WDC's Profile

Stock Price

WDC's Financials

Business Description

Fundamentals

Charts & Quotes

WDC's News

Suppliers

WDC's Competitors

Customers & Markets

Economic Indicators

WDC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071